Literature DB >> 18956820

[Study on the venoms of the principal venomous snakes from French Guiana and the neutralization].

J Estévez1, P Magaña, J P Chippaux, N Vidal, R Mancilla, J F Paniagua, A R de Roodt.   

Abstract

We studied some biochemical, toxic and immunological characteristics of the venoms of Bothrops atrox, Bothrops brazili and Lachesis muta, Viperidae responsible for most of the bites of venomous snakes in French Guiana. Chromatographic (HPLC) and electrophoretical profiles (SDS-PAGE), lethal, hemorrhagic, defibrinogenating, coagulant, thrombin like, proteolytic, fibrino(geno)lytic and phospholipase activities were studied. In addition, the neutralization of some toxic activities conferred by four antivenins was compared. The chromatographic and electrophoretic profiles were different for the three venoms, showing differences between Bothrops and L. muta venoms. In general, bothropic venoms showed the highest toxic and enzymatic activities, while the venom of L. muta showed the lowest lethal, hemorrhagic and coagulant activities. The enzymes of bothropic venoms responsible for gelatinolytic activity were around 50-90 kDa. All the venoms were able to hydrolyze a and beta chains of the fibrinogen, showing different patterns of degradation. Although all the antivenoms tested were effective to various degrees in neutralizing the venom of B. brazili and B. atrox, neutralization of L. muta venom was significantly better achieved using the antivenom including this venom in its immunogenic mixture. For the neutralization of L. muta venom, homologous or polyvalent antivenoms that include the "bushmaster" venom in their immunogenic mixture should be preferred.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956820     DOI: 10.3185/pathexo3174

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  2 in total

1.  High mortality due to snakebites in French Guiana: Time has come to re-evaluate medical management protocols.

Authors:  Rémi Mutricy; Xavier Heckmann; Maylis Douine; Christian Marty; Anne Jolivet; Véronique Lambert; Frédérique Perotti; David Boels; Sébastien Larréché; Jean-Philippe Chippaux; Mathieu Nacher; Loïc Epelboin
Journal:  PLoS Negl Trop Dis       Date:  2018-07-19

Review 2.  Global Availability of Antivenoms: The Relevance of Public Manufacturing Laboratories.

Authors:  José María Gutiérrez
Journal:  Toxins (Basel)       Date:  2018-12-24       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.